Skip to main content
. 2019 Apr 15;11(4):541. doi: 10.3390/cancers11040541
CA19-9 Carbohydrate Antigen 19-9
CI confidence interval
CSCs Cancer stem cells
CTLA-4 cytotoxic T-lymphocyte-associated antigen 4
DAPI 4′,6-diamidino-2-phenylindole
DFS disease-free survival
FFPE formalin-fixed paraffin- embedded
H&E Hematoxylin and eosin
HR hazard ratio
IF immunofluorescence
IHC immunohistochemistry
MDSC myeloid derived suppressor cells
NSCLC non-small cell lung cancer
OS overall survival
PC pancreatic cancer
PD-1 programmed death 1
PD-L1 programmed death receptor ligand-1
PFS progression-free survival
TILs tumor- infiltrating lymphocytes